Adalimumab - Safe and Effective Therapy for an Adolescent Patient with Severe Psoriasis and Immune Thrombocytopenia. 
Psoriasis has been linked to several comorbidities, including metabolic syndrome, atopy, and celiac disease.  However, the association between immune thrombocytopenia and psoriasis has rarely been described.  We report the case of an adolescent with severe psoriasis and concomitant immune thrombocytopenia who obtained remission during treatment with adalimumab.  Increased concentration of tumor necrosis factor-α seems to be a pathogenic linkage and therapeutic target for both diseases.